Ocular Therapeutix, Inc.
OCUL
$11.87
-$0.43-3.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -56.65% | -67.19% | -139.68% | -159.98% | -52.50% |
| Total Depreciation and Amortization | 5.18% | 12.49% | 26.92% | 50.76% | 74.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.25% | -23.06% | 337.19% | 2,419.99% | 135.94% |
| Change in Net Operating Assets | 156.13% | 146.37% | -38.04% | -489.41% | -92.53% |
| Cash from Operations | -97.92% | -72.86% | -91.75% | -81.81% | -26.65% |
| Capital Expenditure | -102.27% | -0.10% | 78.84% | 80.14% | 79.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -94.69% | -0.10% | 78.84% | 80.14% | 79.37% |
| Total Debt Issued | -- | -- | -- | -100.00% | 4,023.70% |
| Total Debt Repaid | -- | -- | -- | 100.00% | -1,206.25% |
| Issuance of Common Stock | -74.40% | -96.57% | 179.88% | 3,879.24% | 3,996.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -77.11% | -96.93% | 95.56% | 601.54% | 4,480.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.45% | -133.02% | 109.77% | 3,143.46% | 678.41% |